Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$655M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$353M |
| 3 |
BCE
BCE
|
+$336M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$326M |
| 5 |
GSK
GSK
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$567M |
| 2 |
Intel
INTC
|
+$349M |
| 3 |
Microsoft
MSFT
|
+$338M |
| 4 |
Boeing
BA
|
+$328M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.46% |
| 2 | Technology | 10.17% |
| 3 | Healthcare | 8.68% |
| 4 | Communication Services | 7.76% |
| 5 | Industrials | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
CALL
Nike
NKE
$60.4B
| $4.96M | ﹤0.01% |
60,000
-327,200
| -85% | -$30.4M |
|
1777
State Street SPDR MSCI USA StrategicFactors ETF
QUS
$1.59B
| $4.96M | ﹤0.01% |
64,984
+11,854
| +22% | +$1.07M |
|
1778
PUT
Intuitive Surgical
ISRG
$139B
| $4.95M | ﹤0.01% |
30,000
| – | – |
|
|
VRN
1779
DELISTED
Veren
VRN
| $4.94M | ﹤0.01% |
6,428,837
-1,879,746
| -23% | -$5.19M |
|
1780
CALL
Takeda Pharmaceutical
TAK
$56.3B
| $4.93M | ﹤0.01% |
325,000
| – | – |
|
|
1781
PUT
Takeda Pharmaceutical
TAK
$56.3B
| $4.93M | ﹤0.01% |
325,000
| – | – |
|
1782
BioMarin Pharmaceuticals
BMRN
$13B
| $4.93M | ﹤0.01% |
58,353
+4,168
| +8% | +$359K |
|
|
VCRA
1783
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $4.92M | ﹤0.01% |
231,659
+2,762
| +1% | +$62.8K |
|
1784
PUT
TechnipFMC
FTI
$30.8B
| $4.92M | ﹤0.01% |
+980,045
| New | +$10.8M |
|
1785
iShares US Equity Factor ETF
LRGF
$3.74B
| $4.89M | ﹤0.01% |
184,881
+7,305
| +4% | +$235K |
|
1786
First Trust Europe AlphaDEX Fund
FEP
$536M
| $4.87M | ﹤0.01% |
187,977
+67,862
| +56% | +$2.28M |
|
1787
CRISPR Therapeutics
CRSP
$5.18B
| $4.86M | ﹤0.01% |
114,657
+6,420
| +6% | +$331K |
|
1788
Onto Innovation
ONTO
$20.3B
| $4.86M | ﹤0.01% |
163,793
+25,281
| +18% | +$864K |
|
1789
American Financial Group
AFG
$12.1B
| $4.86M | ﹤0.01% |
69,314
+4,037
| +6% | +$390K |
|
1790
Exelixis
EXEL
$12.7B
| $4.85M | ﹤0.01% |
281,679
-85,769
| -23% | -$1.57M |
|
1791
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.38B
| $4.84M | ﹤0.01% |
48,914
-98,131
| -67% | -$9.78M |
|
1792
iShares International Treasury Bond ETF
IGOV
$1.53B
| $4.84M | ﹤0.01% |
98,118
+6,134
| +7% | +$307K |
|
|
EVBG
1793
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $4.83M | ﹤0.01% |
45,457
-49,739
| -52% | -$4.88M |
|
1794
PUT
Kraft Heinz
KHC
$30.3B
| $4.82M | ﹤0.01% |
195,000
-30,000
| -13% | -$823K |
|
1795
BlackRock Health Sciences Trust
BME
$570M
| $4.82M | ﹤0.01% |
133,574
+57,937
| +77% | +$2.31M |
|
1796
Celanese
CE
$5.01B
| $4.81M | ﹤0.01% |
65,540
-50,875
| -44% | -$5.03M |
|
1797
Virtus Biotech ETF
BBP
$106M
| $4.81M | ﹤0.01% |
128,405
+18,357
| +17% | +$759K |
|
1798
iShares Morningstar US Equity ETF
ILCB
$1.32B
| $4.81M | ﹤0.01% |
131,176
-76,216
| -37% | -$3.34M |
|
1799
Franklin US Low Volatility High Dividend Index ETF
LVHD
$632M
| $4.8M | ﹤0.01% |
186,237
-18,175
| -9% | -$573K |
|
1800
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.99B
| $4.8M | ﹤0.01% |
158,133
-4,236
| -3% | -$161K |
|
Similar funds
Royal Bank of Canada's Q1 2020 Portfolio in Review
As of Q1 2020, Royal Bank of Canada held 7,387 positions worth $208B, down 25% from $277B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada withdrew a net $12.3B in Q1 2020, closing 516 positions and reducing 2,931 holdings. Its most notable exit was Liberty Property Trust, an estimated $227M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Royal Bank of Canada opened a new position in GFL Environmental worth $84M.
- Royal Bank of Canada's largest Q1 2020 buy was GFL Environmental: 5,584,075 shares worth $84M.
- Royal Bank of Canada added most to iShares MSCI EAFE ETF in Q1 2020, an estimated $655M increase.
- Royal Bank of Canada's biggest Q1 2020 reduction was Apple, cutting an estimated $567M.
- Royal Bank of Canada fully exited Liberty Property Trust in Q1 2020, selling an estimated $227M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $208B portfolio in Q1 2020.
- Royal Bank of Canada opened 432 new positions and closed 516 in Q1 2020.
- Royal Bank of Canada's portfolio value fell 25% quarter-over-quarter to $208B.
Based on Royal Bank of Canada's 13F filing for Q1 2020, filed 15 May 2020.